A retrospective study to evaluate Modeling-based response-guided therapy for chronic hepatitis C under glecaprevir/pibrentasvir treatment
Latest Information Update: 08 May 2020
At a glance
- Drugs Glecaprevir/pibrentasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
Most Recent Events
- 08 May 2020 New trial record
- 04 May 2020 Results published in the Journal of Infectious Diseases